2nd Quarter - Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$730,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Settlements

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
PAUL ROMNESS —
ALANNA PORTER TEMME —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Shortages; Supply Chain Security; Risk Evaluation and Mitigation Strategies (REMs); Compounding

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
ALANNA PORTER TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Illegal Compounding

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
ALANNA PORTER TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Rebates for Dual Eligibles and Low Income Subsidy Populations in Medicare Part D; Importation; Non Interference; Supply Chain Security; Patent Settlements

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
ALANNA PORTER TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.